BioAge Labs, Inc. (BIOA)
21.32
+1.16
(+5.75%)
USD |
NASDAQ |
Jan 20, 16:00
20.74
-0.58
(-2.72%)
After-Hours: 20:00
BioAge Labs EPS Diluted (Quarterly): -0.5626 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 6.211 |
| Perspective Therapeutics, Inc. | -0.3495 |
| Electromed, Inc. | 0.246 |
| InfuSystem Holdings, Inc. | 0.1078 |
| Xtant Medical Holdings, Inc. | 0.0087 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -20.17M |
| Revenue (Quarterly) | 2.054M |
| Total Expenses (Quarterly) | 22.22M |
| Enterprise Value | 485.78M |
| Gross Profit Margin (Quarterly) | 97.61% |
| Profit Margin (Quarterly) | -982.0% |
| Earnings Yield | -9.92% |
| Normalized Earnings Yield | -9.959 |